Sentences with phrase «blood testing company»

Directed by Adam McKay, Jennifer is to star as Elizabeth Holmes, the founder of a blood testing company Theranos.

The chief executive of embattled Theranos Inc on Monday presented plans for a new product and said the blood testing company was working diligently to rectify all of its outstanding issues involving its product and laboratory operations.

Among them, have been blood testing company Theranos, whose technology was called into question in a series of reports by the Wall Street Journal.

Keeping an eye on blood test results is what Elizabeth Holmes, founder of the revolutionary blood test company Theranos, thinks will transform medicine and help people find out they are sick sooner in life.

Not exact matches

For $ 999 per year up front or $ 99 monthly, customers will use a kit sent by the company each quarter to take blood, urine, stool, and saliva samples, and then send them back for testing.

The story said that the vast majority of Theranos's blood tests were not run on its own machines, and that instead, the company was using machines purchased from others.

And early this month he invested millions in a company that's creating a simple blood test to detect every form of cancer.

Theranos is the first company to start using blood tests that primarily rely on microfluidics, and it says it gets unparalleled results.

On Oct. 15, The Wall Street Journal (WSJ) published an investigative report that claims the company does not use its own «revolutionary» blood testing technology, called Edison, for the majority of lab testing, largely because of concerns about accuracy.

Theranos, a company founded by Stanford sophomore Elizabeth Holmes in the fall of 2003 (she dropped out a few months later) has generated a lot of buzz for developing a revolutionary approach to the blood test.

«We can perform hundreds of tests, from standard to sophisticated, from a pinprick and tiny sample of blood, and we have performed more than 70 tests from a single tiny sample,» a representative for the company told Tech Insider in April.

Holmes has been stripped of control of the blood - testing company she founded, is returning millions of shares to Theranos, and is barred from serving as an officer or director of a public company for 10 years, the SEC said in a statement Wednesday.

It's been a roller coaster year for Theranos, a startup once heralded as a revolutionary blood - testing company.

It did submit data from its herpes blood test to the FDA (which approved it), but a former Theranos employee cited by the Journal said that, at the end of 2014, the company only used its technology for 15 blood tests out of at least 225.

Traditional lab companies like Quest have also started talking about using blood tests for a personalized medicine approach to the early detection of diseases.

Elizabeth Holmes, the founder of Theranos, had said her company could accurately perform a wide range of tests using a only a few drops of blood.

U.S. federal health regulators have proposed banning Theranos Inc. founder Elizabeth Holmes from the blood - testing business for at least two years after determining that the company failed to fix deficiencies at its California laboratory, the Wall Street Journal reported on Wednesday.

As Theranos continues to spiral downward, its investors are now claiming the company threatened to file for bankruptcy protection if they don't give up their rights to sue the startup over its faulty blood - testing business, Bloomberg reported.

Even the company's own employees have concerns about Theranos» blood tests.

The beleaguered blood technology company told officials at the Centers for Medicare and Medicaid Services that it tossed all test results from its Edison devices from 2014 and 2015, according to the Wall Street Journal, citing anonymous sources.

Holmes and Theranos made waves in Silicon Valley and the diagnostics industry two years ago, when investors lined up to boost the valuation of a company that claimed it would soon offer more than 1,000 varieties of blood diagnostics tests without the need for a syringe.

Holmes did confirm that the company, only «as of a few weeks ago,» is using only one «finger prick» blood test commercially, but says that was her own decision, based on her desire to get FDA approval for its process.»

The first complaint accused the company of instructing employees to test patients» blood using Theranos» devices even though there was evidence of «major stability, precision, and accuracy» issues.

Freenome, headquartered in South San Francisco, is one of a slew of so - called liquid biopsy (i.e., blood test) companies to break out over the past few years.

But then, the secretive company's claims it could run a full range of tests from a few drops a blood had yet to be vetted by anyone.

The first incident, according to The Journal, involved a blood test ordered in 2013 for a patient using the company's proprietary Edison lab machine.

April 10 - Embattled blood - testing company Theranos Inc laid off most of its remaining workforce to preserve cash and avert or at least delay bankruptcy for a few more months, the Wall Street Journal reported on Tuesday, citing people familiar with the matter.

And as founder Elizabeth Holmes unveiled a new blood - testing device on Monday at the American Association for Clinical Chemistry's annual scientific meeting, it's a good time to take another look at the company.

In 2003, 19 - year - old Elizabeth Holmes dropped out of Stanford and founded a company that can run multiple blood tests on a single drop of blood.

ASH 2016 has been one of the most anticipated scientific conventions of the year, with companies like Novartis, Kite, and Juno presenting critical new data about a next - gen set of drugs that are being tested in numerous blood cancers.

Another device, called Scanadu Scanaflo, is a urine test kit that the company says can test for levels of glucose, protein, leukocytes, nitrates, blood, bilirubin, urobilinogen, specific gravity, and pH in urine.

A U.S. health regulator has barred blood - testing company Theranos Inc.'s founder and CEO, Elizabeth Holmes, from operating a lab for at least two years, the latest blow for a company that is under scrutiny for the accuracy and quality of its tests.

Theranos was once praised for its fast, less - invasive blood testing technology but the company has found itself in the spotlight after media reports raised questions about the accuracy of its proprietary tests.

Theranos is a $ 9 billion biotech company that has a new approach to blood testing.

The company used to focus on blood testing and animal health care.

Or if The Wall Street Journal hadn't revealed problems with Theranos» blood tests, Walgreens (wag) may not have suspended its lab testing with the company in California.

Multiple outlets published stories yesterday reporting that results from finger blood tests by medical startup Theranos showed greater irregularities than more conventional tests (according to the first published independent assessment of the company's tests).

Plus, Gates recently invested alongside Jeff Bezos in Grail, the company that's creating a blood test to detect every form of cancer.

Theranos was once praised for its fast, less - invasive blood testing technology, but the company has found itself in the spotlight after media reports raised questions about the accuracy of its proprie...

The company's Gene - RADAR system can be used at the actual hospitals where patients go; it's portable, making it an especially convenient system for Zika virus testing since blood samples don't have to be shipped off to diagnostic labs.

Theranos is a diagnostics company with fast finger - prick blood testing technology that aims to upend the traditional health care establishments by making it easier, less expensive and less uncomfortable to get tested for various conditions.

Other companies facing similar questions about whether they can make good on early investor expectations — and lofty private - market valuations — include online storage service Dropbox Inc., note - taking company Evernote Corp., music - streaming service Deezer SA and blood - testing company Theranos Inc., said Anand Sanwal, chief executive officer of CB Insights, a firm that tracks startup investing.

Indeed, the 25 - person company has now tested thousands of blood samples, and it says its tests outperform current screening tests on the market for four types of cancer: prostate, breast, colorectal, and lung.

(Reuters)- U.S. federal health regulators have proposed banning Theranos Inc founder Elizabeth Holmes from the blood - testing business for at least two years after determining that the company failed to fix deficiencies at its California laboratory, the Wall Street Journal reported on Wednesday.

Theranos, a privately held company founded by Ms. Holmes, 31, after she dropped out of Stanford at age 19, has been trying to swat down suspicions that the capability it has promoted — being able to do a wide range of medical tests cheaply and quickly using only a finger prick of blood — is more hype than reality.

About ChipCare ChipCare is a Toronto - based company producing life - saving diagnostics for infectious and non-communicable diseases in remote health settings with a mobile, simple - to - use & lab quality blood - testing platform.

With lead investment from Puffin Partners, the Ontario, Canada - based company is taking lifesaving blood - testing technology to low - and middle - income countries.

Theranos first came under scrutiny in October 2015, when the two - time Pulitzer - prize winning WSJ journalist John Carreyrou published an explosive investigative piece, suggesting that the company — then valued by investors at a stunning $ 9 billion — had greatly exaggerated its abilities to quickly process an expansive range of laboratory tests from a few drops of blood.

Prior to joining Oberon, David was Chief Financial Officer and Treasurer at VolitionRx (NYSE MKT: VNRX), a multi-national medical diagnostics company developing simple blood - based tests to accurately diagnose a range of cancers.

The patch never made it to market, but Holmes quickly redirected the company with the creation of «Edison» — a machine that could test for a variety of disease using a single pinprick of blood.